What does IMMOCOV do?

IMMOCOV is a property company in Gent. Cooperative, started on 1 January 1968, 1 establishment.

What is the address of IMMOCOV?

The registered office of IMMOCOV is located at Nieuwevaart 151, 9000 Gent.

Is IMMOCOV still active?

Yes. According to the CBE (29 October 2026) IMMOCOV is active, legal situation “Normale toestand”, started on 1 January 1968.

Is IMMOCOV registered on Peppol?

Yes, IMMOCOV is registered on the Peppol network with ID 0208:0401036305.

What is the enterprise number of IMMOCOV?

The enterprise number of IMMOCOV is BE0401036305.

When was IMMOCOV founded?

IMMOCOV was founded on 1 January 1968.

Who are the directors of IMMOCOV?

According to the 2025 annual accounts, the directors of IMMOCOV are: G. REYNEBEAU, S. MISSELYN, M. DE MOOR, J. ROOSE, R. CORBEIJ, A. CLAUWAERT, W. VERMEYLEN, S. TEMMERMAN.

Is IMMOCOV a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 January 1968; 5 annual accounts filed, latest fiscal year 2025; 8 directors known from the annual account.

How much profit did IMMOCOV make in 2025?

IMMOCOV posted a profit after taxes of € 1,119,471 in financial year 2025.

What is the revenue of IMMOCOV?

As a small company, IMMOCOV is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 2,211,677.

IMMOCOV (Cooperative) - Gent - BE0401036305

Dossier IMMOCOV, printed on 29 October 2026 from databakkes.be/en/0401036305/immocov. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 38 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

IMMOCOV from Gent, company number BE0401036305, closed financial year 2025 with a result of € 1.1 million after tax. For that financial year IMMOCOV recorded a gross margin of € 2.2 million and equity of € 22.9 million. Compared with financial year 2024, the result moved from € 217,277 to € 1.1 million. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.

What it is worth Healthy

€ 22.9 million

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 1.1 million

▲ € 902,194 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 57,158

▲ 101% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 4.3 million.

People and assets in 2025

Vehicles and equipment

€ 6,785

▼ 11% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 11 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 3.1 million

▼ 5% vs 2024

€ 283,657 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.

Owed to suppliers

€ 82,516

▲ 202% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 55,153

▲ 63% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 688,918 Gross margin 2022: € 688,918 First fiscal year in the series	€ 854,980 Gross margin 2023: € 854,980 ▲ 24% vs 2022 (€ 688,918) Favourable step	€ 999,049 Gross margin 2024: € 999,049 ▲ 17% vs 2023 (€ 854,980) Favourable step	€ 2,211,677 Gross margin 2025: € 2,211,677 ▲ 121% vs 2024 (€ 999,049) Favourable step	▲ 121%
Profit after taxes	€ 162,784 Profit after taxes 2022: € 162,784 First fiscal year in the series	€ 174,369 Profit after taxes 2023: € 174,369 ▲ 7% vs 2022 (€ 162,784) Favourable step	€ 217,277 Profit after taxes 2024: € 217,277 ▲ 25% vs 2023 (€ 174,369) Favourable step	€ 1,119,471 Profit after taxes 2025: € 1,119,471 ▲ € 902,194 vs 2024 (€ 217,277) Favourable step	▲ € 902,194
Equity	€ 23,498,127 Equity 2022: € 23,498,127 First fiscal year in the series	€ 23,672,496 Equity 2023: € 23,672,496 ▲ 1% vs 2022 (€ 23,498,127) Favourable step	€ 23,805,385 Equity 2024: € 23,805,385 ▲ 1% vs 2023 (€ 23,672,496) Favourable step	€ 22,859,587 Equity 2025: € 22,859,587 ▼ 4% vs 2024 (€ 23,805,385) Unfavourable step	▼ 4%
Total debts	€ 3,832,914 Total debts 2022: € 3,832,914 First fiscal year in the series	€ 5,441,269 Total debts 2023: € 5,441,269 ▲ 42% vs 2022 (€ 3,832,914) Unfavourable step	€ 3,697,916 Total debts 2024: € 3,697,916 ▼ 32% vs 2023 (€ 5,441,269) Favourable step	€ 3,544,413 Total debts 2025: € 3,544,413 ▼ 4% vs 2024 (€ 3,697,916) Favourable step	▼ 4%
Cash	€ 115,916 Cash 2022: € 115,916 First fiscal year in the series	€ 79,371 Cash 2023: € 79,371 ▼ 32% vs 2022 (€ 115,916) Unfavourable step	€ 28,398 Cash 2024: € 28,398 ▼ 64% vs 2023 (€ 79,371) Unfavourable step	€ 57,158 Cash 2025: € 57,158 ▲ 101% vs 2024 (€ 28,398) Favourable step	▲ 101%
Land & buildings	€ 25,258,463 Land & buildings 2022: € 25,258,463 First fiscal year in the series	€ 25,093,573 Land & buildings 2023: € 25,093,573 ▼ 1% vs 2022 (€ 25,258,463) Unchanged	€ 25,919,127 Land & buildings 2024: € 25,919,127 ▲ 3% vs 2023 (€ 25,093,573) Unchanged	€ 24,187,244 Land & buildings 2025: € 24,187,244 ▼ 7% vs 2024 (€ 25,919,127) Unchanged	▼ 7%
Retained profit	€ 2,750,482 Retained profit 2022: € 2,750,482 First fiscal year in the series	€ 2,924,851 Retained profit 2023: € 2,924,851 ▲ 6% vs 2022 (€ 2,750,482) Favourable step	€ 3,142,127 Retained profit 2024: € 3,142,127 ▲ 7% vs 2023 (€ 2,924,851) Favourable step	€ 4,261,598 Retained profit 2025: € 4,261,598 ▲ 36% vs 2024 (€ 3,142,127) Favourable step	▲ 36%
Bank debt	€ 1,812,353 Bank debt 2022: € 1,812,353 First fiscal year in the series	€ 3,235,932 Bank debt 2023: € 3,235,932 ▲ 79% vs 2022 (€ 1,812,353) Unfavourable step	€ 3,228,079 Bank debt 2024: € 3,228,079 Unchanged (€ 3,235,932) Favourable step	€ 3,076,389 Bank debt 2025: € 3,076,389 ▼ 5% vs 2024 (€ 3,228,079) Favourable step	▼ 5%
Balance sheet total	€ 27,863,787 Balance sheet total 2022: € 27,863,787 First fiscal year in the series	€ 29,606,863 Balance sheet total 2023: € 29,606,863 ▲ 6% vs 2022 (€ 27,863,787) Unchanged	€ 27,956,750 Balance sheet total 2024: € 27,956,750 ▼ 6% vs 2023 (€ 29,606,863) Unchanged	€ 27,104,428 Balance sheet total 2025: € 27,104,428 ▼ 3% vs 2024 (€ 27,956,750) Unchanged	▼ 3%

Key figures of IMMOCOV, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to IMMOCOV?

What happened at IMMOCOV in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 3, 2026 New annual accounts for financial year 2025: profit of € 1.1 million (▲ € 902,194 vs 2024). Source: NBB ↗
Jan 1, 1968 Start of the company according to the CBE. KBO
Nov 1, 1926 New establishment in Gent. KBO

In short

From € 162,784 profit in 2022 to € 1.1 million profit in 2025.

Paid € 455,746 in corporate taxes since 2022.

Best year ever: 2025, with € 1.1 million profit.

Original PDFs at the National Bank ↗

Management

VOORUIT NR. 1 90.2%

The stake of VOORUIT NR. 1 comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

IMMOCOV

Coop-Apotheken Erkende CVSO 21.8%

Behind IMMOCOV are G. REYNEBEAU, S. MISSELYN, M. DE MOOR, J. ROOSE, R. CORBEIJ and A. CLAUWAERT. The shares are held by VOORUIT NR. 1 (90.2%). It owns 21.8% of Coop-Apotheken Erkende CVSO itself.

Directors

According to the 2025 annual accounts

G. REYNEBEAU

Director

Also active at: VOORUIT NR. 1, COOP-APOTHEKEN

S. MISSELYN

Director

Also active at: VOORUIT NR. 1, COOP-APOTHEKEN, SERVICOV

M. DE MOOR

Director

Also active at: VOORUIT NR. 1, COOP-APOTHEKEN, SERVICOV

J. ROOSE

Director

Also active at: VOORUIT NR. 1, COOP-APOTHEKEN, SERVICOV

R. CORBEIJ

Chairman of the board

Also active at: VOORUIT NR. 1, COOP-APOTHEKEN

A. CLAUWAERT

Director

Also active at: VOORUIT NR. 1, COOP-APOTHEKEN, SERVICOV

W. VERMEYLEN

Director

Also active at: VOORUIT NR. 1, COOP-APOTHEKEN, SERVICOV

S. TEMMERMAN

Director

Also active at: VOORUIT NR. 1, COOP-APOTHEKEN, SERVICOV

Shareholders

VOORUIT NR. 1

90.2%

Participations

Coop-Apotheken Erkende CVSO

21.8%

Establishments

Establishment units

Physical locations of this company

Registered office

Nieuwevaart 151

9000 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.

All companies at this address →

VOORUIT NR. 1 same network

€ 3.6 million revenue · 2025

Fonds Eduard Anseele

COOP-APOTHEKEN same network

€ 85.3 million revenue · 2025

COOP APOTHEKEN

FARMALINE

€ 12,450 gross margin · 2025

+3 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0401.036.305
VAT number: BE 0401.036.305
Registered office: Nieuwevaart 151, 9000 Gent
Names & denominations: IMMOCOV
Enterprise type: Rechtspersoon
Legal form: Cooperative company
Legal situation: Normale toestand
Start date: 1 January 1968
Peppol: Active · Active since 14 Dec 2025
Activities · NACE: Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

View on CBE Public ↗ Annual accounts (NBB) ↗

IMMOCOV

Warning lights

Financials

What happened to IMMOCOV?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions